Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report

Hyperuricemia is associated with the progression of chronic kidney disease (CKD) and cardiovascular diseases. Topiroxostat, a selective xanthine oxidase inhibitor, effectively reduces serum uric acid (UA) levels and urinary albumin excretion (UAE) in CKD patients. A 50-year-old Japanese man was refe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Atsushi, Nakamura, Tsukasa, Sato, Eiichi, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318337/
https://www.ncbi.nlm.nih.gov/pubmed/28074335
http://dx.doi.org/10.1007/s40268-016-0169-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318337/
https://www.ncbi.nlm.nih.gov/pubmed/28074335
http://dx.doi.org/10.1007/s40268-016-0169-1

Ejemplares similares